EUROFINS SCIENT Shares Outstanding 2018-2026 | ERFSF
EUROFINS SCIENT shares outstanding history from 2018 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- EUROFINS SCIENT shares outstanding for the quarter ending June 30, 2026 were 0M, a 0% increase year-over-year.
- EUROFINS SCIENT 2024 shares outstanding were 0.195B, a 1.72% decline from 2023.
- EUROFINS SCIENT 2023 shares outstanding were 0.198B, a 0.55% decline from 2022.
- EUROFINS SCIENT 2022 shares outstanding were 0.199B, a 0.8% decline from 2021.
|
EUROFINS SCIENT Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 195 |
| 2023 | 198 |
| 2022 | 199 |
| 2021 | 201 |
| 2020 | 196 |
| 2019 | 186 |
| 2018 | 183 |
| 2017 | 180 |
| 2016 | 160 |
|
EUROFINS SCIENT Quarterly Shares Outstanding (Millions of Shares) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.369B | $8.253B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||